Post by Grifols

Today, June 11, we mark #DINDay 2026 — a global awareness day dedicated to Dysimmune & Inflammatory Neuropathies (DIN).    More than 1.3 million people worldwide are living with these rare neurological conditions, often facing long journeys to diagnosis, limited access to treatment and daily physical challenges.    DIN includes a group of rare autoimmune disorders affecting the peripheral nerves, such as Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).    At Grifols, we are proud to collaborate globally with patient organizations supporting the GBS|CIDP community, including, among others, GBS|CIDP Foundation International (US), GBS/CIDP Foundation of Canada and EPODIN (Europe).    DIN Day is not just a date — it’s a call to action.  A moment to amplify patient voices, raise awareness and push for better diagnosis, care and research. For more info, visit dinday.org.